Aster DM Quality Care Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Aster DM Quality Care Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: ₹4 per ₹100 of sales comes from others' credit, against ₹16 tied up three years earlier. Less money tied up than 95% of Healthcare companies in India.
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹21 of operating cash. Lower than 88% of Healthcare companies in India.
- Growth Efficiency Ratio: Sales grew 55% in 3 years, but profit fell: ₹2 less profit per ₹100 of extra sales. Lower than 88% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹21Over the last 3 years, every ₹100 of reported profit came with ₹21 of operating cash.
Lower than 88% of Healthcare companies in India.
Self-Funding Ratio
0.8×Over the last 3 years its own operating cash paid for 76% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 73% of Healthcare companies in India.
Cash Locked Ratio
−₹4Money owed to suppliers is larger than money owed by customers plus stock: ₹4 per ₹100 of sales comes from others' credit, against ₹16 tied up three years earlier.
Less money tied up than 95% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 68% of Healthcare companies in India.
Growth Efficiency Ratio
−₹2Sales grew 55% in 3 years, but profit fell: ₹2 less profit per ₹100 of extra sales.
Lower than 88% of Healthcare companies in India.
Asset Productivity Ratio
+55% / -45%In 3 years sales changed by +55% while total assets changed by -45%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
4.6×Debt due within a year is covered 4.6 times by its yearly operating cash.
Higher than 69% of Healthcare companies in India.
Cash Cushion Ratio
−2%Debt, after subtracting cash, equals 2% of its market value (net debt).
Lower than 51% of Healthcare companies in India.
Tangible Assets Ratio
96%Of every ₹100 the company owns, ₹96 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 55% of Healthcare companies in India.
Tangible Net Worth Ratio
94%Of every ₹100 of net worth, ₹94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 56% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Aster DM Quality Care Limited owes ₹0.40 for every ₹1 it owns. Net profit fell 93% in the year to Mar 2026, and shrank 3% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
106.1Investors pay ₹106.1 for every ₹1 of Aster DM Quality Care Limited's yearly profit, higher than 92% of Healthcare companies in India.
P/B ratio
12.47The share price is 12.47 times Aster DM Quality Care Limited's book value per share, higher than 89% of Healthcare companies in India.
Market cap
₹57,068 CrThe total market value of all of Aster DM Quality Care Limited's shares at today's price (share price × number of shares), larger than 90% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹4,576 CrWhat Aster DM Quality Care Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹52.50Net worth divided by the number of shares. The share price of ₹654.70 is 12.5 times this, which is the P/B above.
Return on equity (ROE)
7.0%Aster DM Quality Care Limited earned 7.0% on its shareholders' money over the last year, lower than 78% of Healthcare companies in India.
Owes vs Owns
0.40×Aster DM Quality Care Limited owes ₹0.40 for every ₹1 it owns (low), higher than 60% of Healthcare companies in India.
Dividend yield
0.57%Aster DM Quality Care Limited pays 0.57% of its share price as dividends a year, higher than 67% of dividend-paying Healthcare companies in India.
Revenue growth
+12%Revenue rose 12% in the year to Mar 2026, and grew 16% a year on average over 3 years.
Profit growth
-93%Net profit fell 93% in the year to Mar 2026, and shrank 3% a year on average over 3 years.
Profit margin
8.5%Aster DM Quality Care Limited keeps ₹8 of every ₹100 of revenue as net profit.
Cash quality
1.7×Cash from Aster DM Quality Care Limited's business was 1.7× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
6.6×Aster DM Quality Care Limited's operating profit covered its interest costs 6.6 times in the year to Mar 2026.
Cash vs debt
Net debtAster DM Quality Care Limited had ₹1,068 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Aster DM Quality Care Limited's P/E ratio?
Investors pay ₹106.1 for every ₹1 of Aster DM Quality Care Limited's yearly profit, higher than 92% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Aster DM Quality Care Limited: ₹57,068 Cr ÷ ₹4,576 Cr (31 Mar 2026) = 12.5.
What is Aster DM Quality Care Limited's return on equity?
Aster DM Quality Care Limited earned 7.0% on its shareholders' money over the last year, lower than 78% of Healthcare companies in India.
How much does Aster DM Quality Care Limited owe compared with what it owns?
Aster DM Quality Care Limited owes ₹0.40 for every ₹1 it owns (low), higher than 60% of Healthcare companies in India.
Does Aster DM Quality Care Limited pay a dividend?
Yes. Aster DM Quality Care Limited pays 0.57% of its share price as dividends a year, higher than 67% of dividend-paying Healthcare companies in India.
Is Aster DM Quality Care Limited's revenue growing?
Revenue rose 12% in the year to Mar 2026, and grew 16% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.